Correlation Between Sonnet Biotherapeutics and ZyVersa Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and ZyVersa Therapeutics, you can compare the effects of market volatilities on Sonnet Biotherapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and ZyVersa Therapeutics.

Diversification Opportunities for Sonnet Biotherapeutics and ZyVersa Therapeutics

0.25

Correlation Coefficient

Sonnet Biotherapeutics  ZyVersa Therapeutics

Modest diversification

The 3 months correlation between Sonnet and ZyVersa is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and ZyVersa Therapeutics

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 3.12 times more return on investment than ZyVersa Therapeutics. However, Sonnet Biotherapeutics is 3.12 times more volatile than ZyVersa Therapeutics. It trades about 0.12 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  129.00  in Sonnet Biotherapeutics Holdings on May 7, 2025 and sell it today you would earn a total of  152.00  from holding Sonnet Biotherapeutics Holdings or generate 117.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	86.89%
Values	Daily Returns

Sonnet Biotherapeutics Holding  vs.  ZyVersa Therapeutics

Sonnet Biotherapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

ZyVersa Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Sonnet Biotherapeutics and ZyVersa Therapeutics

The main advantage of trading using opposite Sonnet Biotherapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.

The idea behind Sonnet Biotherapeutics Holdings and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.